Thus, it was implied that crosstalk between YAP1 and CDK6 seems to play a pivotal role in conferring radiation resistance and targeting both YAP1 and CDK6 could be a useful therapeutic strategy to treat both esophageal adenocarcinoma and squamous cell carcinoma. This evidence concerns the gene YAP1 and esophageal adenocarcinoma.